Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan et al

Ann Rheum Dis. 2022 Aug;81(8):e149. doi: 10.1136/annrheumdis-2020-218441. Epub 2020 Jul 24.
No abstract available

Keywords: antirheumatic agents; immune system diseases; therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Malaysia / epidemiology
  • Rheumatic Diseases* / complications